Class II · Moderate risk
Ascorbic Acid 500 mg/ml Injectable Vial
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
FDA Drug Recalls
6,161 recalls · Class II, newest first
Class II · Moderate risk
L-Arginine 100 mg/ml Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Alprostadil 50 mcg/ml Injection
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Alprostadil 40 mcg/ml Injection
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Alprostadil 20 mcg/ml Injection
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Alprostadil 100 mcg/ml Injection
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Alprostadil 10 mcg/ml Injection
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Acetylcysteine 100 mg/ml Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Acetyl-L-Carnitine 500 mg/ml
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Acetyl-L-Carnitine 250 mg/ml Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
5-Methy Tetrahydrofolate 5 mg/ml Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
5-Methyl Tetrahydrofolate
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Gentamicin Sulfate
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Ganciclovir Sodium
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Fluorouracil 4250mg / D5W 285mL
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
HYDROmorphone HCl PF
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Ceftazidime 2 gm / NS 50mL
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Morphine Sulfate
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Cefepime HCl
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Potassium Chloride
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Vancomycin 1000mg / NS 100mL
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Vancomycin 750 mg/NS 100 ml accuflo
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
GENTAMICIN 14.4 mg / NS 30 mL SYRINGE
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Pfizerpen-G 4.2 MU / SW 240 mL AccuFlo
Lack of Assurance of Sterility: Sterility of product is not assure
Class II · Moderate risk
Cefepime HCl
Lack of Assurance of Sterility: Sterility of product is not assured